Crescent Biopharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 4.13 M | $49.02 M | 192.19% | 4.55% |
| BVF INC/IL | 02/17/2026 | 2.75 M | $32.60 M | 98.06% | 3.03% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 2.75 M | $32.59 M | 97.99% | 3.02% |
| VR ADVISER, LLC | 02/17/2026 | 2.13 M | $25.30 M | 53.73% | 2.35% |
| FCPM III SERVICES B.V. | 02/17/2026 | 1.68 M | $19.90 M | 100.00% | 1.85% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 1.50 M | $17.79 M | 100.00% | 1.65% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 1.18 M | $13.97 M | 100.00% | 1.30% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 872.40 K | $10.35 M | 28.33% | 0.96% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 606.00 K | $7.19 M | 100.00% | 0.67% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 600.00 K | $7.12 M | 0.00% | 0.66% |
| VANGUARD GROUP INC | 01/29/2026 | 557.51 K | $6.61 M | -15.26% | 0.61% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 453.69 K | $5.38 M | 0.00% | 0.50% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 453.69 K | $5.38 M | 0.00% | 0.50% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 453.69 K | $5.38 M | 0.00% | 0.50% |
| RTW INVESTMENTS, LP | 02/17/2026 | 372.86 K | $4.42 M | 100.00% | 0.41% |
| 02/13/2026 | 372.86 K | $4.42 M | 100.00% | 0.41% | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 338.13 K | $4.01 M | -11.85% | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 302.46 K | $3.59 M | 0.00% | 0.33% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 300.00 K | $3.56 M | 100.00% | 0.33% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 02/17/2026 | 264.00 K | $3.13 M | 100.00% | 0.29% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 264.00 K | $3.11 M | 100.00% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 143.41 K | $1.63 M | 710.33% | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 125.22 K | $1.49 M | 342.21% | 0.14% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 111.72 K | $1.32 M | 100.00% | 0.12% |
| BLACKROCK, INC. | 02/12/2026 | 109.23 K | $1.30 M | 0.11% | 0.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 91.08 K | $1.08 M | 31.74% | 0.10% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 87.68 K | $1.04 M | 100.00% | 0.10% |
| BLACKSTONE INC. | 02/17/2026 | 75.61 K | $896.78 K | 0.00% | 0.08% |
| WOODLINE PARTNERS LP | 02/17/2026 | 74.00 K | $877.64 K | 100.00% | 0.08% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 74.00 K | $844.34 K | 100.00% | 0.08% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 64.24 K | $761.93 K | -37.45% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 61.88 K | $733.92 K | 100.00% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 57.05 K | $676.59 K | 100.00% | 0.06% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 46.70 K | $553.86 K | 73.61% | 0.05% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 32.50 K | $385.45 K | 100.00% | 0.04% |
| MORGAN STANLEY | 02/13/2026 | 27.52 K | $326.40 K | 18,880.00% | 0.03% |
| STATE STREET CORP | 02/13/2026 | 26.22 K | $310.93 K | 40.82% | 0.03% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 25.25 K | $299.41 K | -31.72% | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 02/17/2026 | 25.00 K | $296.50 K | 100.00% | 0.03% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 24.90 K | $288.95 K | -0.08% | 0.03% |
| JANE STREET GROUP, LLC | 02/12/2026 | 22.97 K | $272.37 K | 100.00% | 0.03% |
| MARSHALL WACE, LLP | 02/13/2026 | 21.83 K | $258.86 K | -50.05% | 0.02% |
| NORTHERN TRUST CORP | 02/17/2026 | 17.23 K | $204.34 K | 2.46% | 0.02% |
| HRT FINANCIAL LP | 02/12/2026 | 13.08 K | $155.00 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 23.34 K | $276.80 K | 137,188.24% | 0.01% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 11.60 K | $137.58 K | 100.00% | 0.01% |
| UBS GROUP AG | 01/29/2026 | 7.13 K | $84.50 K | -43.72% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 5.57 K | $66.10 K | 44.27% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 3.59 K | $42.52 K | 89,525.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 623 | $7.39 K | -21.93% | 0.00% |
Crescent Biopharma Inc. institutional Ownership - FAQ's
During the previous two years, 77 institutional investors and hedge funds held shares of Crescent Biopharma Inc.. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 152,974
UBS Group AG: 82,706
VANGUARD FIDUCIARY TRUST CO: 49,423
CITIGROUP INC: 20,169
BNP PARIBAS ARBITRAGE, SNC: 15,694
Cannon Global Investment Management, LLC: 10,200
26.13% of Crescent Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 23.91 M shares in the last 24 months. This purchase volume represents approximately $287.43 M in transactions.